Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Can New Psoriasis Drugs Scratch Investors' Itch?
Can New Psoriasis Drugs Scratch Investors' Itch?
Can New Psoriasis Drugs Scratch Investors' Itch?
Submitted by
admin
on April 4, 2013 - 1:52pm
Source:
Investors.com
News Tags:
investors
psoriasis
Amgen
Eli Lilly
Pfizer
Novartis
Celgene
Humira
AbbVie
Stelara
Remicade
Enbrel
apremilast
brodalumab
Xeljanz
Headline:
Can New Psoriasis Drugs Scratch Investors' Itch?
Do Not Allow Advertisers to Use My Personal information
